作者: C.J van Marrewijk , G Fransen , R.J.F Laheij , P.L Harris , J Buth
DOI: 10.1016/J.EJVS.2003.10.016
关键词:
摘要: Abstract Objective. There is still debate whether type II endoleaks represent a risk for the patient after EVAR. Treatment policies vary from fairly conservative to active intervention. In this analysis factors endoleak and adverse events during follow-up were assessed. addition, causes conversion open repair rupture post-EVAR studied. Methods. The data of 3595 patients, who underwent operation between 1996 2002 in 114 European institutions that collaborated EUROSTAR Registry, To accurately assess influence patients with I, III combined excluded present study cohort. Results. A outcome event consisting aneurysmal growth, transfemoral reintervention, transabdominal secondary procedures (including laparoscopic branch vessel clipping) occurred 55% at 3 years, compared 15% without any (p Conclusion. Endoleak may not be harmless as it was more frequently associated enlargement aneurysm reinterventions. Large aneurysms migration device main rupture. clinical implications these findings involve frequent surveillance visits endoleak. Aneurysm expansion clear indication reintervention. Patients large aneurysms, 65 mm or larger, also benefit comprehensive schedule.